FDA Continues Clinical Hold on Insmed (INSM) ARIKACE Phase 3; More Info Needed
Go back to FDA Continues Clinical Hold on Insmed (INSM) ARIKACE Phase 3; More Info Needed| INSMED (NASDAQ: INSM) | Delayed: 126.81 +1.73 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.08 | 52 Week High | $19.30 | |||
| Open | $125.22 | 52 Week Low | $9.02 | |||
| Day High | $127.20 | P/E | N/A | |||
| Day Low | $124.82 | EPS | $-1.69 | |||
| Volume | 263,121 | |||||
